AHCO (AdaptHealth Corp. Common Stock)
Insider Trading Activity
Every open-market purchase and sale reported by AHCO officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-14 | DALE B WOLF | Director | Buy | — | — |
| 2026-08-10 | KENNETH A SAMET | Director | Buy | — | — |
| 2026-08-10 | DALE B WOLF | Director | Buy | — | — |
| 2026-07-06 | III Russell E. Schuster | Chief Commercial Officer | Sell | — | — |
| 2026-06-26 | Susan T Weaver | Director | A | — | — |
| 2026-06-26 | Bradley J Coppens | Director | A | — | — |
| 2026-06-26 | KENNETH A SAMET | Director | A | — | — |
| 2026-06-26 | DALE B WOLF | Director | A | — | — |
| 2026-06-26 | Theodore B. Lundberg | Director | A | — | — |
| 2026-06-26 | GREGORY BELINFANTI | Director | A | — | — |
| 2026-06-26 | David Solomon Williams III | Director | A | — | — |
| 2026-06-26 | Terence J Connors | Director | A | — | — |
| 2026-06-03 | III Russell E. Schuster | Chief Commercial Officer | Sell | — | — |
| 2026-05-29 | Daniel Edward McFadden | Chief Operating Officer | A | — | — |
| 2026-04-28 | Albert A. Prast | Chief Technology Officer | F | — | — |
| 2026-03-30 | OEP AHCO Investment Holdings, LLC | 10%+ Owner | Buy | — | — |
| 2026-03-30 | ONE EQUITY PARTNERS VII, L.P. | 10%+ Owner | Buy | — | — |
| 2026-03-23 | RICHARD M CASHIN JR | 10%+ Owner | Buy | — | — |
| 2026-03-16 | Albert A. Prast | Chief Technology Officer | MIXED | — | — |
| 2026-03-12 | RICHARD M CASHIN JR | 10%+ Owner | Buy | — | — |
| 2026-03-09 | Susan T Weaver | Director | G | — | — |
| 2026-03-03 | DALE B WOLF | Director | Buy | — | — |
| 2026-02-27 | Richard W. Rew II | CLO and General Counsel | Buy | — | — |
| 2026-02-03 | Albert A. Prast | Chief Technology Officer | A | — | — |
| 2026-02-03 | Suzanne Foster | Chief Executive Officer | A | — | — |
| 2026-02-03 | Jason A Clemens | Chief Financial Officer | A | — | — |
| 2026-02-03 | Toby Scott Barnhart | Chief Operating Officer | A | — | — |
| 2026-02-03 | Daniel Edward McFadden | Chief Business Systems Officer | A | — | — |
| 2026-02-03 | Richard W. Rew II | CLO and General Counsel | A | — | — |
| 2026-02-03 | III Russell E. Schuster | Chief Commercial Officer | A | — | — |
| 2026-02-03 | Christine E. Archbold | Chief Accounting Officer | A | — | — |
| 2026-01-13 | GREGORY BELINFANTI | Director | A | — | — |
| 2026-01-13 | Theodore B. Lundberg | Director | A | — | — |
| 2025-12-05 | David Solomon Williams III | Director | Sell | — | — |
| 2025-08-22 | David Solomon Williams III | Director | Sell | — | — |
| 2025-06-30 | David Solomon Williams III | Director | A | — | — |
| 2025-06-30 | Terence J Connors | Director | A | — | — |
| 2025-06-30 | Diana L Nole | Director | A | — | — |
| 2025-06-30 | Susan T Weaver | Director | A | — | — |
| 2025-06-30 | Theodore B. Lundberg | Director | A | — | — |
| 2025-06-30 | Bradley J Coppens | Director | A | — | — |
| 2025-06-30 | GREGORY BELINFANTI | Director | A | — | — |
| 2025-06-30 | DALE B WOLF | Director | A | — | — |
| 2025-02-04 | Suzanne Foster | Chief Executive Officer | A | — | — |
| 2025-02-04 | Richard W. Rew II | CLO and General Counsel | A | — | — |
| 2025-02-04 | Albert A. Prast | Chief Technology Officer | A | — | — |
| 2025-02-04 | Jason A Clemens | Chief Financial Officer | A | — | — |
| 2025-02-04 | Christine E. Archbold | Chief Accounting Officer | A | — | — |
| 2025-02-04 | Toby Scott Barnhart | Chief Operating Officer | A | — | — |
| 2025-02-04 | III Russell E. Schuster | Chief Commercial Officer | A | — | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| — | 10%+ Owner | 16,312,698 | — |
| — | 10%+ Owner | 15,865,598 | — |
| — | 10%+ Owner | 14,638,708 | — |
| — | 10%+ Owner | 13,818,180 | — |
| — | 10%+ Owner | 12,805,008 | — |
| — | 10%+ Owner | 11,643,769 | — |
| — | 10%+ Owner | 10,930,471 | — |
| — | Director | 8,705,870 | — |
| — | Director | 8,591,948 | — |
| — | Director | 8,556,857 | — |
| — | Director | 8,439,295 | — |
| — | Director | 5,136,387 | — |
| — | Interim CEO | 4,110,855 | — |
| — | Chief Executive Officer | 3,975,242 | — |
| — | Director | 3,243,256 | — |
| — | Director | 3,043,056 | — |
| — | Director | 2,220,277 | — |
| — | Co-Chief Executive Officer | 1,492,953 | — |
| — | President | 967,876 | — |
| — | Chief Executive Officer | 924,050 | — |
| — | Director | 892,495 | — |
| — | Chief Financial Officer | 673,481 | — |
| — | Chief Technology Officer | 338,712 | — |
| — | General Counsel | 223,742 | — |
| — | Chief Operating Officer | 220,654 | — |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the AHCO quote page; the site-wide leaderboard is on the insider transactions hub.